BRIEF: XtalPi shares surge on Microsoft China partnership
AI pharmaceutical company XtalPi Inc. (2228.HK) on Monday announcedit has entered into a strategic cooperation memorandum with Microsoft China for new drug and materials development. Under the tie-up, the two parties…
InSilico seeks IPO boost to get AI drugs over the line
The drug developer has raised around $400 million in seven rounds of financing. But after burning through cash, the company needs fresh capital to sustain its work on AI-assisted drugs…
RELATED ARTICLES
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK - InSilico seeks IPO boost to get AI drugs over the line
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
-
AsiaInfo reboots with founder’s return, big investor’s departure
1675.HK 688225.SHG
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
